|1.||Morishita, Ryuichi: 18 articles (01/2014 - 05/2002)|
|2.||Anitua, Eduardo: 15 articles (10/2015 - 02/2007)|
|3.||Orive, Gorka: 14 articles (10/2015 - 02/2008)|
|4.||Achen, Marc G: 14 articles (01/2014 - 07/2002)|
|5.||Stacker, Steven A: 13 articles (06/2013 - 07/2002)|
|6.||Lyman, Gary H: 12 articles (10/2013 - 11/2003)|
|7.||Meldrum, Daniel R: 12 articles (08/2011 - 06/2004)|
|8.||Yarden, Yosef: 11 articles (03/2015 - 02/2003)|
|9.||Konturek, S J: 11 articles (09/2006 - 12/2000)|
|10.||Petraglia, Felice: 10 articles (12/2015 - 01/2002)|
03/01/2007 - "Recent excitement has been generated by the clinical efficacy of targeted antiangiogenic therapy against growth factors important in angiogenesis and tumor proliferation. "
07/01/2009 - "Since angiogenesis is crucial for tumor growth, a better understanding of the potential clinical relevance as well as the interactions between the numerous proangiogenic growth factors is essential to develop improved therapeutic strategies in these tumors. "
01/01/2009 - "Advances in neutrophil biology coupled with better understanding and development of myeloid growth factors offer great promise for improving the care of patients with cancer and many other disorders."
01/01/2008 - "growth factors and their receptors), it was hoped that new targeted agents, by inhibiting cancer-specific pathways, would spare normal cells and thereby offer improved safety benefits and a higher therapeutic index over standard chemotherapeutics. "
06/01/1990 - "In the field of cancer therapy the major benefit of the haemopoietic growth factors will be if they permit dosage escalation and there is a consequent improvement in response rate and long-term survival. "
|2.||Wounds and Injuries (Trauma)
08/01/1993 - "Growth factors are extremely potent biologic agents that show promise in accelerating wound repair in both animal and human studies. "
01/01/2010 - "However, the exogenous application of growth factors to chronic wounds has not proven to be effective in healing them. "
09/24/2008 - "Growth factors are known to act in concert to promote wound repair, but their topical application rarely leads to a significant clinical improvement of chronic wounds due to premature inactivation in wound environment. "
06/01/1990 - "The animals treated with growth factors also had significantly greater wound closure at 21 days than those treated with the vehicle. "
04/01/2011 - "These results suggest that simple uniform distributions of growth factors immobilized to an extracellular matrix material may be as effective in directing cell migration into a wound site as more complex patterns with concentration gradients."
11/01/1999 - "Hematopoietic growth factors accelerate the recovery from treatment-induced neutropenia and may improve the remission rate, remission duration, and even overall survival. "
11/01/1988 - "Early studies in animals and in humans suggest that these cell growth factors are effective in correcting neutropenia."
08/01/1995 - "There is increasing evidence that haemopoietic growth factors are effective in reversal of neutropenia associated with large granular lymphocytes (LGLs) proliferation. "
05/01/2013 - "During the 1990 s he was one of the first in Europe who have used hematopoietic growth factors as a supportive therapy in the protocol ALL-BFM and has also helped to set up the International Registry for Severe Chronic Neutropenias [SCNIR] in his Department. "
01/01/1998 - "Grade 3 and 4 neutropenia occurred, respectively in 30% and 23% of the cycles; 6% of the cycles benefited from medullary growth factors. "
09/01/1997 - "Such changes in growth factors could be important in a variety of processes that occur during infection, such as protection against injury or tissue repair and recovery processes."
01/01/1993 - "We conclude that myeloid growth factors are effective for the treatment and prevention of acute infections and chronic inflammatory complications in patients with GSD Ib."
05/01/2012 - "The Bim-dependent intrinsic pathway of apoptosis removes effector CD8 T cells upon clearance of viral infection, which is driven by withdrawal of growth factors. "
01/01/2011 - "Evidence from ALL trials is mixed with some studies suggesting a reduction of severe infections by myeloid growth factors whereas others report no effect. "
05/15/2007 - "This study investigates whether dose modifications for adverse hematologic effects or the use of hematopoietic growth factors influenced the outcome of therapy for hepatitis C virus (HCV) infection in patients who were coinfected with HCV and human immunodeficiency virus (HIV) and who were participants in a randomized, controlled trial. "
12/01/1993 - "Several growth factors are showing promising results in clinical trials, especially in cases of impaired healing, such as chronic ulcers. "
11/01/2007 - "This study tests the hypothesis that addition of a protease-modulating matrix enhances the efficacy of autologous growth factors in diabetic ulcers. "
12/01/1997 - "Furthermore, we believe that in some patients ulcer healing may be improved by exogenous provision of specific growth factors."
06/15/2001 - "In particular, the ulcer-healing model using the cultured monolayer is promising and convenient for the study of several growth factors such as HGF as well as antiulcerogenic agents. "
03/01/2000 - "Growth factors in ulcer healing: lessons from recent studies."
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|3.||Epidermal Growth Factor (EGF)
|5.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|6.||Granulocyte Colony-Stimulating Factor (G-CSF)
|8.||Insulin-Like Growth Factor I (IGF-1)
|9.||Proteins (Proteins, Gene)
|1.||Drug Therapy (Chemotherapy)
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|4.||Tissue Therapy (Cell Therapy)